Bilodeau; Mark T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bilodeau; Mark T..The latest application filed is for "targeted conjugates encapsulated in particles and formulations thereof".
Company Profile
28.61.91
- Bilodeau; Mark T. - Waltham MA
- Bilodeau; Mark T. - Concord MA
- Bilodeau; Mark T. - Lansdale PA
- Bilodeau; Mark T. - Landsdale PA US
- Bilodeau; Mark T - Lansdale PA US
- Bilodeau; Mark T. - Harleysville PA US
- Bilodeau; Mark T. - Harleyhsville PA
- Bilodeau; Mark T. - Landale PA
- Bilodeau; Mark T. - New York NY
Patent Activity
| Patent | Date |
|---|---|
| Targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20220288229 - Bilodeau; Mark T. ; et al. | 2022-09-15 |
| Hsp90-binding Conjugates And Combination Therapies Thereof App 20220257777 - BLOSS; Jeffrey ; et al. | 2022-08-18 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20220185836 - BILODEAU; Mark T. ; et al. | 2022-06-16 |
| Hsp90-binding Conjugates And Formulations Thereof App 20220184217 - White; Brian H. ; et al. | 2022-06-16 |
| Sstr-targeted Conjugates And Particles And Formulations Thereof App 20220096646 - Wooster; Richard ; et al. | 2022-03-31 |
| Hsp90-targeting Conjugates And Formulations Thereof App 20220096640 - Moreau; Beno t ; et al. | 2022-03-31 |
| HSP90-targeting conjugates and formulations thereof Grant 11,241,500 - Moreau , et al. February 8, 2 | 2022-02-08 |
| Hsp90-targeting Conjugates And Formulations Thereof App 20220031853 - WHITE; Brian H. ; et al. | 2022-02-03 |
| SSTR-targeted conjugates and particles and formulations thereof Grant 11,160,871 - Wooster , et al. November 2, 2 | 2021-11-02 |
| Pharmaceutical Compositions With Reduced Tert-butanol Levels App 20210169871 - BILODEAU; Mark T. ; et al. | 2021-06-10 |
| Hsp90-targeting Conjugates And Formulations Thereof App 20210145971 - Bilodeau; Mark T. ; et al. | 2021-05-20 |
| Hsp90-targeting Conjugates And Formulations Thereof App 20210000966 - Cipriani; Tyler ; et al. | 2021-01-07 |
| Hsp90 Targeted Conjugates And Particle Formulations Thereof App 20200237746 - Shinde; Rajesh R. ; et al. | 2020-07-30 |
| Combination Therapies Comprising Targeted Therapeutics App 20200230247 - Wooster; Richard ; et al. | 2020-07-23 |
| Targeted Therapeutics App 20200230126 - Alland; Leila ; et al. | 2020-07-23 |
| Targeted Conjugates And Particles And Formulations Thereof App 20200206356 - Alargova; Rossitza G. ; et al. | 2020-07-02 |
| Sstr-targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20200121808 - Bilodeau; Mark T. ; et al. | 2020-04-23 |
| Targeted conjugates and particles and formulations thereof Grant 10,624,967 - Alargova , et al. | 2020-04-21 |
| Hsp90 Targeted Conjugates And Particles And Formulations Thereof App 20200113877 - Shinde; Rajesh R. ; et al. | 2020-04-16 |
| Hsp90-targeting Conjugates And Formulations Thereof App 20200085960 - Moreau; Beno t ; et al. | 2020-03-19 |
| Neurotensin Receptor Binding Conjugates And Formulations Thereof App 20200078468 - Bilodeau; Mark T. ; et al. | 2020-03-12 |
| HSP90 targeted conjugates and particles and formulations thereof Grant 10,548,881 - Shinde , et al. Fe | 2020-02-04 |
| Targeted Constructs And Formulations Thereof App 20200009262 - White; Brian H. ; et al. | 2020-01-09 |
| Stapled Peptide Conjugates And Particles App 20190365913 - Wooster; Richard ; et al. | 2019-12-05 |
| Platinum Compounds, Compositions, And Uses Thereof App 20190350940 - Alargova; Rossitza G. ; et al. | 2019-11-21 |
| Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof Grant 10,472,380 - Brockman , et al. Nov | 2019-11-12 |
| Nanoparticle Diagnostic And Methods For Treating Disease App 20190231906 - Kadiyala; Sudhakar ; et al. | 2019-08-01 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20190218241 - Bilodeau; Mark T. ; et al. | 2019-07-18 |
| Platinum compounds, compositions, and uses thereof Grant 10,342,801 - Alargova , et al. July 9, 2 | 2019-07-09 |
| Targeted conjugates and particles and formulations thereof Grant 10,322,191 - Alargova , et al. | 2019-06-18 |
| Platinum compounds, compositions, and uses thereof Grant 10,322,137 - Bilodeau , et al. | 2019-06-18 |
| Compounds, compositions, and methods for the treatment of cancers Grant 10,287,308 - Bilodeau , et al. | 2019-05-14 |
| Targeted Conjugates And Particles And Formulations Thereof App 20190125888 - White; Brian H. ; et al. | 2019-05-02 |
| Antibody Mimic Conjugates And Particles App 20190085034 - Wooster; Richard ; et al. | 2019-03-21 |
| Hsp90 Targeted Conjugates And Particles And Formulations Thereof App 20190054072 - Shinde; Rajesh R. ; et al. | 2019-02-21 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20190015378 - Bilodeau; Mark T. ; et al. | 2019-01-17 |
| Compounds, compositions, and methods for the treatment of cancers Grant 10,111,853 - Bilodeau , et al. October 30, 2 | 2018-10-30 |
| Targeted Constructs And Formulations Thereof App 20180296685 - Wooster; Richard ; et al. | 2018-10-18 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20180273567 - Bilodeau; Mark T. ; et al. | 2018-09-27 |
| Compositions And Methods For Genome Editing App 20180258411 - Kadiyala; Sudhakar ; et al. | 2018-09-13 |
| Platinum Compounds, Compositions, And Uses Thereof App 20180243318 - Alargova; Rossitza G. ; et al. | 2018-08-30 |
| Sstr-targeted Conjugates And Particles And Formulations Thereof App 20180221499 - Wooster; Richard ; et al. | 2018-08-09 |
| Platinum Compounds, Compositions, And Uses Thereof App 20180186823 - Kadiyala; Sudhakar ; et al. | 2018-07-05 |
| Compounds, compositions, and methods for the treatment of cancers Grant 10,011,622 - Bilodeau , et al. July 3, 2 | 2018-07-03 |
| Platinum compounds, compositions, and uses thereof Grant 9,937,187 - Bilodeau , et al. April 10, 2 | 2018-04-10 |
| Targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20180021454 - Bilodeau; Mark T. ; et al. | 2018-01-25 |
| Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds Grant 9,867,821 - Bilodeau , et al. January 16, 2 | 2018-01-16 |
| Platinum Compounds, Compositions, And Uses Thereof App 20180008614 - Bilodeau; Mark T. ; et al. | 2018-01-11 |
| Targeted Conjugates And Particles And Formulations Thereof App 20180000959 - Alargova; Rossitza G. ; et al. | 2018-01-04 |
| Platinum Compounds Having A Heterocycle Ligand, Nanoparticles, And Uses Thereof App 20170349615 - Brockman; Adam H. ; et al. | 2017-12-07 |
| Targeted Conjugates And Particles And Formulations Thereof App 20170312245 - Alargova; Rossitza G. ; et al. | 2017-11-02 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20170313733 - Bilodeau; Mark T. ; et al. | 2017-11-02 |
| Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof Grant 9,771,387 - Brockman , et al. September 26, 2 | 2017-09-26 |
| Targeted conjugates and particles and formulations thereof Grant 9,750,818 - Alargova , et al. September 5, 2 | 2017-09-05 |
| Compounds, compositions, and methods for the treatment of cancers Grant 9,738,672 - Bilodeau , et al. August 22, 2 | 2017-08-22 |
| Targeted Conjugates And Particles And Formulations Thereof App 20170151339 - White; Brian H. ; et al. | 2017-06-01 |
| Targeted Conjugates And Particles And Formulations Thereof App 20170095569 - Alargova; Rossitza G. ; et al. | 2017-04-06 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20170087118 - Bilodeau; Mark T. ; et al. | 2017-03-30 |
| Compounds, compositions, and methods for the treatment of cancers Grant 9,556,214 - Bilodeau , et al. January 31, 2 | 2017-01-31 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20160326201 - Bilodeau; Mark T. ; et al. | 2016-11-10 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20160318962 - Bilodeau; Mark T. ; et al. | 2016-11-03 |
| Platinum Compounds, Compositions, And Uses Thereof App 20160317549 - Bilodeau; Mark T. ; et al. | 2016-11-03 |
| Cabazitaxel-platinum nanoparticles and methods of using same Grant 9,480,657 - Bilodeau , et al. November 1, 2 | 2016-11-01 |
| Platinum compounds, compositions, and uses thereof Grant 9,403,858 - Bilodeau , et al. August 2, 2 | 2016-08-02 |
| Nanoparticle Diagnostic and Methods for Treating Disease App 20160166715 - Kadiyala; Sudhakar ; et al. | 2016-06-16 |
| Platinum Compounds Having A Heterocycle Ligand, Nanoparticles, And Uses Thereof App 20160152646 - Brockman; Adam H. ; et al. | 2016-06-02 |
| Sstr-targeted Conjugates Encapsulated In Particles And Formulations Thereof App 20160074526 - Bilodeau; Mark T. ; et al. | 2016-03-17 |
| Platinum Compounds, Compositions, And Uses Thereof App 20160068557 - Bilodeau; Mark T. ; et al. | 2016-03-10 |
| Leucine-rich repeat kinase enzyme activity Grant 9,233,977 - McCauley , et al. January 12, 2 | 2016-01-12 |
| Compounds, Compositions, And Methods For The Treatment Of Cancers App 20150344511 - Bilodeau; Mark T. ; et al. | 2015-12-03 |
| Cabazitaxel-platinum Nanoparticles And Methods Of Using Same App 20140378427 - Bilodeau; Mark T. ; et al. | 2014-12-25 |
| TRPA1 antagonists Grant 8,829,196 - Bilodeau , et al. September 9, 2 | 2014-09-09 |
| Targeted Conjugates Encapsulated in Particles and Formulations Thereof App 20140187501 - Bilodeau; Mark T. ; et al. | 2014-07-03 |
| Platinum Compounds, Compositions And Methods For The Treatment Of Cancer App 20140088066 - Bilodeau; Mark T. ; et al. | 2014-03-27 |
| Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors Grant 8,592,425 - Altman , et al. November 26, 2 | 2013-11-26 |
| Leucine-rich Repeat Kinase Enzyme Activity App 20130296317 - McCauley; John A. ; et al. | 2013-11-07 |
| Hexahydro-1h-4,7-methanoisoindole-1,3-dione Compounds App 20130178481 - Bilodeau; Mark T ; et al. | 2013-07-11 |
| Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds Grant 8,410,111 - Bilodeau , et al. April 2, 2 | 2013-04-02 |
| Quinolone neuropeptide S receptor antagonists Grant 8,389,720 - Barrow , et al. March 5, 2 | 2013-03-05 |
| Hexahydro-1h-4,7-methanoisoindole-1,3-dione Compounds App 20120316181 - Bilodeau; Mark T. ; et al. | 2012-12-13 |
| Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds Grant 8,252,799 - Bilodeau , et al. August 28, 2 | 2012-08-28 |
| Novel Trpa1 Antagonists App 20120196894 - Bilodeau; Mark T. ; et al. | 2012-08-02 |
| Potassium channel inhibitors Grant 8,148,535 - Trotter , et al. April 3, 2 | 2012-04-03 |
| IMIDAZO[1,2-A]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS App 20120010209 - Altman; Michael D. ; et al. | 2012-01-12 |
| Potassium channel inhibitors Grant 8,067,607 - Bilodeau , et al. November 29, 2 | 2011-11-29 |
| Potassium channel inhibitors Grant 8,030,332 - Trotter , et al. October 4, 2 | 2011-10-04 |
| Quinolone Neuropeptide S Receptor Antagonists App 20110212946 - Barrow; James C. ; et al. | 2011-09-01 |
| Inhibitors of Akt activity Grant 8,003,643 - Bilodeau , et al. August 23, 2 | 2011-08-23 |
| Potassium channel inhibitors Grant 7,973,059 - Wolkenberg , et al. July 5, 2 | 2011-07-05 |
| Inhibitors of Akt activity Grant 7,910,561 - Arruda , et al. March 22, 2 | 2011-03-22 |
| Potassium channel inhibitors Grant 7,879,839 - Dinsmore , et al. February 1, 2 | 2011-02-01 |
| Inhibitors of Akt activity Grant 7,750,151 - Bilodeau , et al. July 6, 2 | 2010-07-06 |
| Therapeutic Agents App 20100105697 - Bilodeau; Mark T. ; et al. | 2010-04-29 |
| Decahydroquinoline Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20100099673 - Bilodeau; Mark T. ; et al. | 2010-04-22 |
| Inhibitors Of Akt Activity App 20100075970 - Bilodeau; Mark T. ; et al. | 2010-03-25 |
| Inhibitors of Akt activity Grant 7,655,649 - Bilodeau , et al. February 2, 2 | 2010-02-02 |
| Potassium Channel Inhibitors App 20100004229 - Bilodeau; Mark T. ; et al. | 2010-01-07 |
| Imidazopyridine Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20090325936 - Bilodeau; Mark T. ; et al. | 2009-12-31 |
| Inhibitors of Akt activity Grant 7,638,530 - Bilodeau , et al. December 29, 2 | 2009-12-29 |
| Potassium Channel Inhibitors App 20090233897 - Trotter; B. Wesley ; et al. | 2009-09-17 |
| Inhibitors of Akt activity Grant 7,579,355 - Bilodeau , et al. August 25, 2 | 2009-08-25 |
| Potassium channel inhibitors Grant 7,569,589 - Bilodeau , et al. August 4, 2 | 2009-08-04 |
| Inhibitors of Akt activity Grant 7,544,677 - Bilodeau , et al. June 9, 2 | 2009-06-09 |
| Potassium Channel Inhibitors App 20090069312 - Trotter; B. Wesley ; et al. | 2009-03-12 |
| Potassium Channel Inhibitors App 20090042944 - Wolkenberg; Scott ; et al. | 2009-02-12 |
| Potassium Channel Inhibitors App 20090030043 - Hoffman; Jacob M. ; et al. | 2009-01-29 |
| Inhibitors of Akt Activity App 20080287457 - Arruda; Jeannie M. ; et al. | 2008-11-20 |
| Inhibitors of Akt Activity App 20080280899 - Bilodeau; Mark T. ; et al. | 2008-11-13 |
| Inhibitors of Akt Activity App 20080280889 - Bilodeau; Mark T. ; et al. | 2008-11-13 |
| Tyrosine kinase inhibitors App 20080274107 - Fraley; Mark E. ; et al. | 2008-11-06 |
| Potassium Channel Inhibitors App 20080090794 - Dinsmore; Christoph J. ; et al. | 2008-04-17 |
| Inhibitors of Akt activity Grant 7,304,063 - Bilodeau , et al. December 4, 2 | 2007-12-04 |
| Inhibitors of Akt Activity App 20070254901 - Bilodeau; Mark T. ; et al. | 2007-11-01 |
| Inhibitors of Akt activity Grant 7,223,738 - Bilodeau , et al. May 29, 2 | 2007-05-29 |
| Inhibitors of akt activity App 20070082906 - Bilodeau; Mark T. ; et al. | 2007-04-12 |
| Tyrosine kinase inhibitors Grant 7,125,888 - Bilodeau , et al. October 24, 2 | 2006-10-24 |
| Tyrosine kinase inhibitors Grant 7,115,597 - Bilodeau , et al. October 3, 2 | 2006-10-03 |
| Potassium channel inhibitors App 20060030595 - Bilodeau; Mark T. ; et al. | 2006-02-09 |
| Tyrosine kinase inhibitors Grant 6,958,340 - Bilodeau , et al. October 25, 2 | 2005-10-25 |
| Tyrosine kinase inhibitors App 20050228031 - Bilodeau, Mark T. ; et al. | 2005-10-13 |
| Inhibitors of akt activity App 20050222155 - Bilodeau, Mark T. ; et al. | 2005-10-06 |
| Tyrosine kinase inhibitors App 20050176753 - Bilodeau, Mark T. ; et al. | 2005-08-11 |
| Tyrosine kinase inhibitors App 20050096344 - Fraley, Mark E. ; et al. | 2005-05-05 |
| (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors Grant 6,875,767 - Bilodeau , et al. April 5, 2 | 2005-04-05 |
| Polymorphs with tyrosine kinase activity Grant 6,872,724 - Zhao , et al. March 29, 2 | 2005-03-29 |
| Tyrosine kinase inhibitors App 20040235867 - Bilodeau, Mark T. ; et al. | 2004-11-25 |
| Tyrosine kinase inhibitors App 20040220201 - Bilodeau, Mark T. ; et al. | 2004-11-04 |
| Tyrosine kinase inhibitors Grant 6,794,393 - Fraley , et al. September 21, 2 | 2004-09-21 |
| Tyrosine kinase inhibitors App 20040063720 - Bilodeau, Mark T. ; et al. | 2004-04-01 |
| Polymorphs with tyrosine kinase activity App 20040023980 - Zhao, Matthew M. ; et al. | 2004-02-05 |
| Active salt forms with tyrosine kinase activity App 20040023978 - Ren, Yu ; et al. | 2004-02-05 |
| Tyrosine kinase inhibitors Grant 6,586,424 - Bilodeau , et al. July 1, 2 | 2003-07-01 |
| Tyrosine kinase inhibitors Grant 6,586,423 - Bilodeau , et al. | 2003-07-01 |
| Tyrosine kinase inhibitors App 20030100567 - Bilodeau, Mark T. ; et al. | 2003-05-29 |
| Tyrosine kinase inhibitors App 20030064996 - Bilodeau, Mark T. ; et al. | 2003-04-03 |
| Angiogenesis inhibitors Grant 6,465,484 - Bilodeau , et al. October 15, 2 | 2002-10-15 |
| Tyrosine kinase inhibitors App 20020147203 - Bilodeau, Mark T. ; et al. | 2002-10-10 |
| Tyrosine kinase inhibitors App 20020137755 - Bilodeau, Mark T. ; et al. | 2002-09-26 |
| Tyrosine kinase inhibitors Grant 6,306,874 - Fraley , et al. October 23, 2 | 2001-10-23 |
| Tyrosine kinase inhibitors Grant 6,245,759 - Bilodeau , et al. June 12, 2 | 2001-06-12 |
| Angiogenesis inhibitors Grant 6,235,741 - Bilodeau , et al. May 22, 2 | 2001-05-22 |
| Tyrosine kinase inhibitors Grant 6,162,804 - Bilodeau , et al. December 19, 2 | 2000-12-19 |
| Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof Grant 6,090,789 - Danishefsky , et al. July 18, 2 | 2000-07-18 |
| Substituted imidazoles having cytokine inhibitory activity Grant 5,859,041 - Liverton , et al. January 12, 1 | 1999-01-12 |
| Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof Grant 5,708,163 - Danishefsky , et al. January 13, 1 | 1998-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 